Letters to the Editor
Letters to the Editor will be published, if suitable, as space permits. They should not exceed 1, 000 words (typed double-spaced) in length and may be subject to editing or abridgment.
Guidelines for Ambulatory Electrocardiography
In light of the ever-increasing need for ambulatory care of cardiac patients, the recently published report of the American College of Cardiology/American Heart Association Task Force on ambulatory electrocardiography is a long-awaited and very important document.
The task force committee has generically defined "ambulatory electrocardiography" to include "all forms of continuous or intermittent recording as well as transtelephonic data transfer." Later in the report, the following important statements are made.
"For patients who experience symptoms daily, a continuous 24 hour ambulatory ECG generally provides useful information . . . However most patients seeking medical attention do not have typical symptoms on a daily basis."
"The need to record the ECG until symptoms occur causes the yield of useful information from ambulatory studies to be heavily dependent on patient selection (especially the frequency of occurrence of symptoms) and the type of system utilized." "The introduction of patient-activated intermittent recorders and transtelephonic ECG capability have greatly aided the evaluation of such patients and have made multiple day 24 hour ambulatory ECGs a cost-ineffective procedure unless the patient's symptoms include abrupt loss of consciousness."
The final and logical conclusion from these statements is clearly formulated: "For patients whose typical symptoms do not occur daily and are not incapacitating, transtelephonic devices would appear to be superior to a single 24 hour recording." Moreover, "these devices are also more cost-effective than multiple 24 hour recordings once the patient's baseline arrhythmias have been characterized by a single conventional 24 hour recording."
As an avid proponent of sophisticated ambulatory management of cardiac patients and, specifically, the use of transtelephonic electrocardiography as a versatile and cost-effective tool,1-3 I was delighted to find these important statements in the committee's report.
Our extensive and long-standing experience with the clinical use of transtelephonic monitoring has lead us to recognize further advantages of the system that merit emphasis. 1) Transtelephonic monitoring constitutes an on-line system providing real-time clinical and electrocardiographic information. The capability of real-time recognition of medical emergencies and prompt on-line intervention is a unique feature of this technique that is not available with Holter monitoring. This important yet generally unrecognized distinction between the two ambulatory monitoring modalities allows one to tailor the ambulatory monitoring system to the specific needs of the patients. Moreover, some of the modern transtelephonic transmitters have amplifier characteristics similar to the conventional ECG recording systems, thereby allowing for accurate detection and documentation of ST-T changes. This indispensable capability is further enhanced by the potential of transtelephonic transmission of at least three ECG leads (equivalent to leads I, II, and III of the 12-lead ECG).' The ability to accurately recognize myocardial ischemia combined with the capability of acute intervention has made transtelephonic ECG monitoring a powerful tool for the long-term ambulatory follow-up of high-risk patients with severe coronary artery disease. This is particularly important for the ambulatory management after hospitalization of patients recovering from an acute myocardial infarction.1,2 2) Transtelephonic ECG monitoring is an ideal tool for longterm ambulatory surveillance (days, weeks, months, and years) for a wide spectrum of indications (long-term monitoring of high-risk patients, such as patients after suffering myocardial infarction, patients after undergoing surgery, ambulatory titration of cardioactive drugs3 etc.).
3) Transtelephonic ECG monitoring is feasible from almost any telephone around the world. With the current sophistication of the telecommunication systems, it provides the patient with almost unlimited mobility. Moreover, the programmability of the modern telephone allows even severely debilitated patients immediate access to the monitoring center with a one button dial. 4) Technologic advancements have lead to the development of various memory equipped devices that can markedly shorten the patient's response time. Some transmitters include a memory loop providing the physician with diagnostically vital retrograde ECG information.
To date, most practicing physicians still regard Holter monitoring as the primary and most effective ambulatory ECG monitoring technique. However, as the committee stressed, the evolution of telecommunications has radically changed today's scene of ambulatory ECG monitoring. Transtelephonic monitoring has become a major and highly cost-effective component of ambulatory electrocardiography.
This letter comes as strong support for the committee's recommendations and is intended to further emphasize the clinical importance of transtelephonic monitoring. It must, however, be restated that both transtelephonic monitoring and Holter monitoring are complementary techniques constituting the main components of a comprehensive and highly effective ambulatory monitoring system. In our opinion, such a combined system, if properly used, forms the basis of a diagnostically accurate, clinically relevant, and cost-effective ambulatory monitoring system applicable to the vast majority of cardiac patients. Daniel vital issue of equipment and personnel requirements needed in the processing of the A-ECG data. Although it is a controversial subject that many may wish to sidestep, physicians worldwide are seeking clarification from the experts in this area. Unfortunately, most physicians, both cardiologists and noncardiologists, lack personal experience in the scanning of Holter tapes. Too few ever sit behind the machine and understand its needed features . . . and all too many purchase equipment without really knowing whether, and if so to what extent, critical scanning features might be missing.
The accuracy of an A-ECG heavily depends on two major factors, and neither should be omitted or compromised. First, the equipment itself must have all of the tools necessary for a qualified analyst to perform a quality study. No matter how good the Holter analysts, they cannot perform miracles with a poorly designed system. Second, only technologists who have been properly trained in Holter scanning should participate in the scanning process. Holter analysts should be at least as proficient in cardiac arrhythmia detection as the average cardiologist . . . because no matter how effective the Holter equipment, an unqualified person (whether technician or physician) can undo everything a good algorithm has accomplished. The physician, therefore, has little chance of catching computer omissions if they have also been missed or corrupted by a careless operator (or by himself, for that matter).
Physicians should not develop a false sense of security with regard to the "benefits" of "personally overviewing" the technologist's reports. If an operator prints artifact, believing it to be an arrhythmia, the physician will have an opportunity to correct the error. However, no matter how skilled the cardiologist, if the operator discards arrhythmia believing it to be artifact, a serious error of omission may occur. Suffice it to say, the physician heavily depends on the skills of the Holter analyst.
Not only is the full disclosure method of printing "insufficient" for detecting subtle cardiac arrhythmias, as the Task Force has stated, it can at times be totally inadequate for detecting ventricular ectopy, ventricular tachycardia (VT), and even episodes of sinus arrest.
In the miniaturized mode, VT is very explicit when interrupting a normal heart rate of 70 beats/min. However, VT is not at all easy to detect with the naked eye when it is buried within a rapid sinus or supraventricular rhythm, or within a 48-page miniaturized report with frequent electrode artifacts (see Figure 1 ).
Likewise, sinus arrest can also be quite easily masked by electrode artifacts whenever the former mimics the latter in the miniaturized printout. Atrioventricular (AV) dissociation, paroxysmal atrial tachycardia with AV block, pacemaker malfunctions, or other intermittent arrhythmias that do not interrupt the RR interval cannot be easily seen-if at all-in this microscopic mode. Physicians must realize that arrhythmias cannot be enlarged if they cannot first be seen in their miniaturized form. A properly designed system (equipment and personnel) is the only logical safeguard against these potential errors of omission.
From a technology standpoint, we strongly believe that all A-ECG systems should be equipped with both visual superimposition scanning and memory paging techniques. Visual superimposition scanning is the technique of rapidly overlaying each ECG complex over the previous complex on a display screen so that interruptions in rhythm, additional P waves, and PR changes (AV dissociation) can easily be seen. Conversely, memory paging typically displays 60 seconds or so of ECG and then refreshes the screen with the next 60 seconds of ECG.
We have found visual superimposition scanning to be the most accurate method for detecting the AV dissociation and conduction defects described above, as well as intermittent preexcitation, QT prolongation, intermittent atrial fibrillation, and supraventricular and junctional rhythms. Conversely, memory paging is the best method for visualizing ventricular pairs, runs of ventricular tachycardia, and ventricular pauses. The advantages of each offset the weaknesses of the other.
American Heart Association Database Tests
Many manufacturers draw on the public American Heart Association (AHA) database tapes to test their algorithms before submission to the Food and Drug Administration (FDA) and subsequently releasing them to the marketplace. However, we are concerned with this practice and the publicizing of these test results. If the public AHA database were used to "fine tune" a particular algorithm during its final development stages, we would expect it to perform flawlessly on subsequent tests against that same database. What we really need to know is: How does the algorithm perform against nonpublic databases or on cardiac patients? Further study by responsible researchers is in order. Further, the issue of whether, and if so to what extent, ECG distortions that result from digital "data compression" techniques are clinically relevant should be quickly investigated. Such techniques are used by the new solid-state recorders to squeeze large amounts of digital data into a limited amount of digital memory. Some of the devices being marketed appear to violate the recommendations set forth in the 1985 American Heart Association Committee on Electrocardiography.
This demonstrates the need for the cardiology community to guide the manufacturers in the proper design of equipment rather than having the manufacturers, through their own engineering and marketing perceptions, dictate the needs of the cardiology community. In my opinion, the ACC and AHA should take a strong position in providing this guidance. Jack E. Lohman Director of Cardiac Evaluation Center, Inc.
Milwaukee, Wisconsin

